FY2027 EPS Estimates for Envista Lowered by Leerink Partnrs

Envista Holdings Co. (NYSE:NVST) – Equities researchers at Leerink Partnrs lowered their FY2027 earnings estimates for shares of Envista in a report issued on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $1.28 for the year, down from their previous forecast of $1.45. The consensus estimate for Envista’s current full-year earnings is $1.00 per share.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%.

A number of other analysts also recently commented on NVST. Morgan Stanley dropped their price target on shares of Envista from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 6th. Piper Sandler boosted their target price on Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Monday, February 3rd. New Street Research set a $19.00 price target on Envista in a research note on Thursday, March 6th. JPMorgan Chase & Co. lowered their price target on Envista from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Thursday, March 6th. Finally, Wells Fargo & Company set a $19.00 price objective on Envista in a report on Saturday, March 8th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $20.18.

Envista Price Performance

Shares of NYSE NVST opened at $15.46 on Monday. The stock has a market cap of $2.66 billion, a P/E ratio of -2.38, a P/E/G ratio of 1.27 and a beta of 1.12. The firm’s 50-day simple moving average is $18.41 and its 200 day simple moving average is $19.35. Envista has a fifty-two week low of $14.22 and a fifty-two week high of $23.00. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44.

Hedge Funds Weigh In On Envista

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Envista during the fourth quarter valued at $53,000. Lecap Asset Management Ltd. acquired a new stake in Envista during the 4th quarter worth about $281,000. Geode Capital Management LLC grew its stake in Envista by 2.5% during the 3rd quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock valued at $57,233,000 after acquiring an additional 71,435 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in shares of Envista by 146.6% in the 4th quarter. Hantz Financial Services Inc. now owns 110,489 shares of the company’s stock valued at $2,131,000 after purchasing an additional 65,679 shares during the period. Finally, Norges Bank purchased a new stake in shares of Envista in the fourth quarter worth approximately $38,052,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.